Illumina Inc (NASDAQ:ILMN)
CAPS Rating:
The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.
The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.
Recs
Company will profit greatly from increased interest in genomic mapping for various diseases and looking at protein interactions with the genome. Beginning to be the new big thing in research and with a high quality reputation.